ESMO® 2026 Highlights: Presenter Vignettes – Hongxia Wang

Dr. Hongxia Wang

Hongxia Wang

PhD

Fudan University Shanghai Cancer Center

5RO

Safety and efficacy of SYS6043, a Novel B7-H3–Targeting Antibody-Drug Conjugate, in Patients with Advanced breast cancer